(Q37779043)

23 August 2017

1 reference

title

Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity (English)

1 reference

23 August 2017

C J Sanchez

1 reference

23 August 2017

T Le Treut

1 reference

23 August 2017

A Boehrer

1 reference

23 August 2017

B Knoblauch

1 reference

23 August 2017

J Imbert

1 reference

23 August 2017

D Olive

1 reference

23 August 2017

R T Costello

1 reference

23 August 2017

publication date

10 August 2010

1 reference

Cancer Immunology, Immunotherapy

23 August 2017

published in

1 reference

23 August 2017

1 reference

23 August 2017

1 reference

23 August 2017

page(s)

1-13

1 reference

Human natural killer cells

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

What is natural in natural killer cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Human natural killer cell receptors and co-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

The NKG2D receptor and its ligands-recognition beyond the "missing self"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Recognition of viral hemagglutinins by NKp44 but not by NKp30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Human natural killer cell receptors: insights into their molecular function and structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. III. Defective interleukin-2 production by T-helper and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Hematopoietic stem cell transplantation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Differential killing of pre-B acute lymphoblastic leukaemia cells by activated NK cells and the NK-92 ci cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Chronic lymphocytic leukaemia cells are efficiently killed by an anti-CD20 monoclonal antibody selected for improved engagement of FcgammaRIIIA/CD16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Regression of engineered myeloma cells secreting interferon-gamma-inducing factor is mediated by both CD4(+)/CD8(+) T and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Can NK cells be a therapeutic target in human cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Development of TLR9 agonists for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

The trafficking of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Proteasome regulation of ULBP1 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Proteasome inhibition induces apoptosis in primary human natural killer cells and suppresses NKp46-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Histone deacetylase inhibitors suppress natural killer cell cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Identification of natural killer cell receptor phenotypes associated with leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-010-0898-X

10.1007/S00262-010-0898-X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference